Estimating Risk of Guillain-Barré Syndrome in US Medicare-enrolled Older Adults Following Medically Attended Respiratory Syncytial Virus Disease: A Self-controlled Case Series Analysis
GBS risk increases after RSV disease compared to control periods not temporally adjacent to RSV disease, with an effect particularly evident among patients aged ≥75 years. RSV should be recognized as one of the pathogens that may rarely lead to GBS.
Authors
- Heidi G. De Souza (ORCID: https://orcid.org/0000-0002-7015-174X)
- Jennifer Judy (ORCID: https://orcid.org/0000-0002-2246-9745)
- Caihua Liang (ORCID: https://orcid.org/0009-0004-8375-631X)
- Erica Chilson (ORCID: https://orcid.org/0000-0002-4417-3398)
- Scott P. Kelly (ORCID: https://orcid.org/0000-0002-0375-1040)
- Bradford D. Gessner (ORCID: https://orcid.org/0000-0002-6216-7194)
- Elizabeth Begier (ORCID: https://orcid.org/0000-0002-1287-5416)
- Jason D Maynard
- Qing Liu (ORCID: https://orcid.org/0000-0003-3733-9078)
Institutions
- Washington State Department of Health (US)
- Pfizer (United States) (US)
- Vhi Healthcare (IE)
- Health Strat (Kenya) (KE)
- Pfizer (Ireland) (IE)
Publication Details
- Journal
- Clinical Infectious Diseases
- Published
- 2025-11-11
- DOI
- https://doi.org/10.1093/cid/ciaf621
- Citations
- 1
- Primary Topic
- Peripheral Neuropathies and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.39